Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress-Reference-Cited by-同舟云学术

Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress

Published:2024-04 Issue: Volume:263 Page:130175
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Kothari Manan,Kannan Karthika,Sahadevan Revathy,Sadhukhan Sushabhan

Funder

Indian Institute of Technology Delhi

Ministry of Education

Indian Institute of Technology Palakkad

Bharathiar University

Council of Scientific & Industrial Research

Indian Institute of Technology Mandi

Science and Engineering Research Board

Department of Science and Technology, Ministry of Science and Technology, India

Publisher

Elsevier BV

Reference61 articles.

1. Mechanisms of diabetic complications;Forbes;Physiol. Rev.,2013

2. Idf Atlas Reports;IDF,2022

3. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults;Green;Diabetologia,2021

4. Diabetic microvascular complications: can patients at risk be identified? A review;Girach;Int. J. Clin. Pract.,2006

5. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture;Janghorbani;Am. J. Epidemiol.,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipophilic derivatives of EGCG as potent α-amylase and α-glucosidase inhibitors ameliorating oxidative stress and inflammation;Bioorganic Chemistry;2024-12

2. Multi-target anti-diabetic styrylpyrones from Phellinus igniarius: Inhibition of α-glucosidase, protein glycation, and oxidative stress;International Journal of Biological Macromolecules;2024-10